LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged motion to amend · clear

PTAB

The Ptab S Important Role in the Policing of Amended Patent Claims

Public Policy Disfavors the Issuance of Unexamined Patent Claims Last November, the PTAB ordered Precedential Opinion Panel (POP) review of the final written decision in Hunting Titan, Inc. v. DynaEnergetics GmbH & Co. KG, Inc., IPR2018-00600. The…

March 5, 2020·PTAB·3 min read
PTAB

PTAB Grants-in-Part Rare Motion to Amend Based on Unexpected Results

Written by Daniel K. Yarbrough, Ph.D. and Benjamin Anger The PTAB granted-in-part a patent owner’s motion to substitute claims based on evidence of secondary considerations of nonobviousness in Valeo North America, Inc. v. Schaeffler Technologies, AG…

June 27, 2017·PTAB·2 min read
PTAB

PTAB Grants-in-Part Motions to Amend in Three Related IPRs

Written by Nathanael Luman , Ph.D. and Kerry S. Taylor, Ph.D. The PTAB granted-in-part motions to amend in three related proceedings: Activision Blizzard, Inc. v. Acceleration Bay, LLC, IPR2015-01953, Paper 107 (P.T.A.B. sealed on March 23, 2017, made…

April 21, 2017·PTAB·2 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.